Menactra | FDA - U.S. Food and Drug Administration
Meningococcal Vaccine Administration | CDC
Meningococcal Vaccine Recommendations - CDC
October 24, 2024. Meningococcal Vaccine Recommendations. Key points. CDC recommends meningococcal vaccination for all adolescents. CDC also recommends meningococcal vaccination for children and adults at increased …
Meningococcal Vaccination | Meningococcal | CDC
Menactra: Package Insert / Prescribing Info - Drugs.com
Jan 15, 2023 · Menactra is indicated for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y and W-135. Menactra is approved for use in individuals 9 months through 55 …
ACIP Updates Recommendations for Meningococcal …
Oct 7, 2020 · Three MenACWY vaccines are licensed for use in the United States: Menactra (for persons age 9 months to 55 years), Menveo (for those age 2 months to 55 years) and MenQuadfi (for those age 2...
Menactra, Menveo (meningococcal A C Y and W-135) …
Meningococcal Vaccination. Indicated for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135 in individuals. 0.5 mL/dose...
Meningococcal Meningitis (MenACWY) Vaccine | MenQuadfi® …
Menactra (Intramuscular) - Drugs.com
- Some results have been removed